AAAAAA
Results:
1-14
|
Results: 14
Authors:
HOCHHAUS A
LIN F
REITER A
SKLADNY H
SHEPHERD PCA
SILL H
ALLAN NC
HEHLMANN R
GOLDMAN JM
CROSS NCP
Citation: A. Hochhaus et al., LEVELS OF MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS IN COMPLETE CYTOGENETIC REMISSION AFTER INTERFERON-ALPHA-THERAPY CORRELATE WITH RISK OF RELAPSE, Experimental hematology, 24(9), 1996, pp. 579-579
Authors:
SHEPHERD PCA
RICHARDS SM
ALLAN NC
Citation: Pca. Shepherd et al., PROGRESS WITH INTERFERON IN CML - RESULTS OF THE MRC-UK-CML-III STUDY, Bone marrow transplantation, 17, 1996, pp. 15-18
Authors:
HOCHHAUS A
REITER A
SKLADNY H
LIN F
REICHERT A
SAUSSELE S
SHEPHERD PCA
ALLAN NC
HEHLMANN R
GOLDMAN JM
CROSS NCP
Citation: A. Hochhaus et al., MOLECULAR HETEROGENEITY IN COMPLETE CYTOGENETIC RESPONDERS AFTER INTERFERON-ALPHA-THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA - LEVELS OF MINIMAL RESIDUAL DISEASE PREDICT RISK OF RELAPSE, Blood, 88(10), 1996, pp. 2644-2644
Authors:
HOCHHAUS A
LIN F
REITER A
SKLADNY H
MASON PJ
VANRHEE F
SHEPHERD PCA
ALLAN NC
HEHLMANN R
GOLDMAN JM
CROSS NCP
Citation: A. Hochhaus et al., QUANTIFICATION OF RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS ON INTERFERON-ALPHA THERAPY BY COMPETITIVE POLYMERASE CHAIN-REACTION, Blood, 87(4), 1996, pp. 1549-1555
Authors:
HOCHHAUS A
LIN F
REITER A
SKLADNY H
VANRHEE F
SHEPHERD PCA
ALLAN NC
HEHLMANN R
GOLDMAN JM
CROSS NCP
Citation: A. Hochhaus et al., MONITORING THE EFFICIENCY OF INTERFERON-ALPHA THERAPY IN CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS BY COMPETITIVE POLYMERASE CHAIN-REACTION, Experimental hematology, 23(8), 1995, pp. 791-791
Authors:
ALLAN NC
RICHARDS SM
SHEPHERD PCA
Citation: Nc. Allan et al., INTERFERON-ALPHA-1 FOR CHRONIC MYELOID-LEUKEMIA - REPLY, Lancet, 346(8986), 1995, pp. 1370-1370
Authors:
ALLAN NC
RICHARDS SM
SHEPHERD PCA
Citation: Nc. Allan et al., UK MEDICAL-RESEARCH-COUNCIL RANDOMIZED, MULTICENTER TRIAL OF INTERFERON-ALPHA-N1 FOR CHRONIC MYELOID-LEUKEMIA - IMPROVED SURVIVAL IRRESPECTIVE OF CYTOGENETIC RESPONSE, Lancet, 345(8962), 1995, pp. 1392-1397
Authors:
HOCHHAUS A
LIN F
REITER A
SKLADNY H
VANRHEE F
SHEPHERD PCA
ALLAN NC
HEHLMANN R
GOLDMAN JM
CROSS NCP
Citation: A. Hochhaus et al., VARIABLE NUMBERS OF BCR-ABL TRANSCRIPTS PERSIST IN CML PATIENTS WHO ACHIEVE COMPLETE CYTOGENETIC REMISSION WITH INTERFERON-ALPHA, British Journal of Haematology, 91(1), 1995, pp. 126-131
Authors:
HOCHHAUS A
REITER A
SKLADNY H
LIN F
MASON PJ
VANRHEE F
SHEPHERD PCA
ALLAN NC
HEHLMANN R
GOLDMAN JM
CROSS NCP
Citation: A. Hochhaus et al., QUANTIFICATION OF RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS ON INTERFERON-ALPHA THERAPY BY COMPETITIVE POLYMERASE CHAIN-REACTION, Blood, 86(10), 1995, pp. 1064-1064
Authors:
HOCHHAUS A
REITER A
MELO JV
SKLADNY H
SHEPHERD PCA
SICK C
CLARK RE
TOBLER A
BELL A
HEHLMANN R
GOLDMAN JM
CROSS NCP
Citation: A. Hochhaus et al., ATYPICAL BCR-ABL TRANSCRIPTS IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS DETECTED BY MULTIPLEX POLYMERASE CHAIN-REACTION, Blood, 86(10), 1995, pp. 2094-2094
Authors:
ALLAN NC
RICHARDS SM
SHEPHERD PCA
Citation: Nc. Allan et al., INTERFERON-ALPHA THERAPY IN CHRONIC MYELOID-LEUKEMIA IS PROBABLY BETTER THAN HYDROXYUREA ALONE, Blood, 86(10), 1995, pp. 2104-2104
Authors:
SHEPHERD PCA
RICHARDS S
ALLAN NC
Citation: Pca. Shepherd et al., SEVERE CYTOPENIAS ASSOCIATED WITH THE SEQUENTIAL USE OF BUSULFAN AND INTERFERON-ALPHA IN CHRONIC MYELOID-LEUKEMIA, British Journal of Haematology, 86(1), 1994, pp. 92-96
Authors:
ALLAN NC
SHEPHERD PCA
RICHARDS SM
Citation: Nc. Allan et al., INTERFERON-ALPHA(IFN-ALPHA) PROLONGS SURVIVAL FOR PATIENTS WITH CML IN CHRONIC PHASE - PRELIMINARY-RESULTS OF THE UK MRC RANDOMIZED MULTICENTER TRIAL, Blood, 84(10), 1994, pp. 10000382-10000382
Authors:
ALLAN NC
SHEPHERD PCA
BRACKENRIDGE I
SUFFOLK R
Citation: Nc. Allan et al., UNITED-KINGDOM MEDICAL-RESEARCH-COUNCIL RANDOMIZED TRIAL OF INTERFERON-ALFA IN CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA, Seminars in hematology, 30(3), 1993, pp. 20-21
Risultati:
1-14
|